Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Cancer ; 15(15): 5046-5057, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39132163

RESUMEN

Colorectal cancer (CRC) is the third most frequent cancer worldwide and the second major cause of cancer-related death. Thus, we attempted to ascertain the relationship between the genotype and allele frequencies of phosphatase and tensin homolog (PTEN) and immunohistochemical PTEN expression with clinicopathological characteristics in patients with CRC. 150 individuals were allocated into two groups for this cross-sectional randomized case-control study: Group I consisted of 100 patients with histopathologically proven CRC of various stages. Group II: Fifty healthy volunteers. Genetic analysis of PTEN (rs701848 T / C) single nucleotide polymorphism (SNP) was performed using TaqManTM assays and real-time PCR, while PTEN expressions were assessed using immunohistochemical staining. PTN SNP genotypes and alleles did not significantly differ between CRC patients and controls. PTEN expression was lost in 28% of CRC patients, while all healthy controls exhibited PTEN expression. Negative PTEN expression was present in 16 (80%) of stage IV CRC cases, 9 (23.7%) of stage III cases, 3 (37.5%) of stage II cases, and none of stage I cases. It was shown that PTEN expression was weakly positive, moderately positive, and strongly positive in 15, 10, and 9 (respectively) cases of CRC stage I. However, the expression was only weekly positive in 4 (20%) of the patients in stage IV. In the stage IV group, neither moderately nor strongly positive PTEN expressions were found. So, Among Egyptians, the emergence or course of colorectal cancer is unrelated to the PTEN gene mutation. However, the formation and progression of CRC may be influenced by weak or lost PTEN expression.

2.
Medicine (Baltimore) ; 101(38): e30650, 2022 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-36197228

RESUMEN

Coronavirus infectious disease 2019 (COVID-19) confirmed cases are characterized by T lymphopenia. Total apoptotic and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expressing cells among CD4+/CD8+ cells were analyzed in 24 COVID-19 patients (16 out-patients and 8 in-patients) and 18 healthy volunteers using flow cytometry to detect their possible role in T lymphopenia. Hospitalized patients did not show significant difference compared to non-hospitalized patients. While the percentage and absolute count of CD4+/CD8+ cells were significantly reduced in COVID-19 cases compared to healthy control (P < .05), the proportion of apoptotic and CTLA-4 expressing CD4+/CD8+ cells were significantly up-regulated in COVID-19 patients (P < .05). In addition, apoptotic and CTLA-4+/CD4+ cells were directly related to dyspnea duration, chest CT score, ferritin, and C-reactive protein and inversely correlated with platelet count in COVID-19 patients. While apoptotic and CTLA-4+/CD8+ cells were directly related to lymphocyte count in COVID-19 patients. The apoptotic and CTLA-4+ cells were directly related to each other in CD4+/CD8+ cells (P < .05). White blood cells (WBCs) (×103/L), eosinophils (ratio and count), lymphocyte ratio, neutrophil ratio, neutrophil/lymphocyte ratio, neutrophil/CD4 ratio, neutrophil/CD8 ratio, CD4+ cells ratio, and CTLA-4+ cells percentage), and CD8+ cells (ratio, count, total apoptotic cell, and CD152 + cells) were all found to be significantly altered in association with COVID-19. Total lymphopenia and depletion of CD4+/CD8+ cells are characterizing COVID-19 patients. Increased apoptosis and CTLA-4 expression in CD4+/CD8+ cells in COVID-19 and their correlations with reduced cell count and severity indicators as CRP and ferritin can be used for diagnosis and follow up of the clinical severity. Our current study proposes promising future diagnostic and therapeutic targets.


Asunto(s)
COVID-19 , Enfermedades Transmisibles , Linfopenia , Proteína C-Reactiva , Linfocitos T CD4-Positivos , Linfocitos T CD8-positivos , Antígeno CTLA-4 , Ferritinas , Humanos
3.
Materials (Basel) ; 14(18)2021 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-34576486

RESUMEN

Layered double hydroxides (LDHs) have emerged as promising electrodes materials for the methanol oxidation reaction. Here, we report on the preparation of different LDHs with the hydrothermal process. The effect of the divalent cation (i.e., Ni, Co, and Zn) on the electrochemical performance of methanol oxidation was investigated. Moreover, nanocomposites of LDHs and carbon xerogels (CX) supported on nickel foam (NF) substrate were prepared to investigate the role of carbon xerogel. The results show that NiFe-LDH/CX/NF is an efficient electrocatalyst for methanol oxidation with a current density that reaches 400 mA·m-2 compared to 250 and 90 mA·cm-2 for NiFe-LDH/NF and NF, respectively. In addition, all LDH/CX/NF nanocomposites show excellent stability for methanol oxidation. A clear relationship is observed between the electrodes crystallite size and their activity to methanol oxidation. The smaller the crystallite size, the higher the current density delivered. Additionally, the presence of carbon xerogel in the nanocomposites offer 3D interconnected micro/mesopores, which facilitate both mass and electron transport.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA